SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which confirms that another major automotive OEM has successfully completed technical benchmarking of the company's solid-state battery technology. While the community is debating the timeline of this partnership, investors are closely watching for further OEM disclosures and updates on manufacturing scale as the stock attempts to build momentum on this latest validation.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following record quarterly revenue and the milestone achievement of positive operating cash flow, signaling a significant transition toward profitability. Investors are actively discussing the company's strategic pivot into semiconductor-based licensing and its growing AI-integrated imaging partnerships.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors focus on the company's QNX platform and the upcoming Baird conference, with strong community discussion centered on its potential as a foundational software layer for the physical AI and robotics sectors. The stock is seeing high trading volume and increased institutional interest, with supporters emphasizing its transition to a recurring subscription model and long-term growth prospects in software-defined vehicles.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mount Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending as the community closely monitors the company's pending acquisition of the Covelya Group and anticipates a significant revenue boost in upcoming earnings. Investors remain highly bullish on the stock's long-term defense-sector tailwinds and institutional growth, with many actively accumulating shares during recent market volatility in anticipation of future exchange uplistings.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing intense downward pressure and volatility as investors weigh a strong quarterly earnings report against concerns that emerging AI agentic tools could disrupt its core SaaS business model. While some in the community see the stock as a deeply undervalued 'steal' supported by strong cash reserves and institutional accumulation, others are aggressively betting on further downside, citing an ongoing rotation out of traditional software and fears that AI-native startups will erode future growth.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense community debate over its extreme price volatility and poor performance compared to other assets, leading many to speculate about further downside risks. Investors are actively discussing the project's long-term utility in real-world asset tokenization versus concerns over tokenomics, inflation, and a perceived lack of buying interest.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending as traders speculate on its potential role in autonomous defense software and recent volatility, with community sentiment deeply divided between bullish investors banking on government contracts and bearish voices dismissing the stock as a heavily manipulated pump-and-dump scheme. Active discussions are heavily focused on the stock's wild price swings, the impact of recent geopolitical tensions on the drone sector, and intense debates over whether its limited revenue justifies its current valuation.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is currently the subject of intense community debate as investors weigh the company's path to an NDA submission for AXPAXLI against pending litigation from competitor EyePoint Pharmaceuticals. While bulls remain encouraged by recent regulatory alignment and the potential for a first-in-class product, others are focused on the stock's recent volatility and broader market pressure on the biotech sector.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is trending as excitement mounts over the upcoming Grand Theft Auto VI, with investors closely watching for the official start of pre-orders and the release of the third trailer. The community is heavily focused on the stock's long-term revenue potential from recurring digital sales and the impact of the anticipated November launch on the company's valuation.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle Corp is experiencing significant momentum as investors digest recent analyst upgrades, positive lithium pricing trends, and increased demand from the battery storage sector. The community is actively discussing its recovery from cyclical lows and the potential impact of strategic cost-cutting measures and shifting global supply chains on its long-term outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

Equity

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


Should You Buy Ardelyx (ARDX)?

Ardelyx (NASDAQ:ARDX) Trading Up 7.4% - What's Next?

Ardelyx (NASDAQ:ARDX) Shares Up 7.4% - What's Next...

FY2030 Earnings Forecast for Ardelyx Issued By HC Wainwright

Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Research analysts at HC Wainwright cut their FY2030 earnings per share estimates for Ardelyx in a research note issued on Friday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the biopharmaceutical company will earn $1.60 per share for th...

AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX

AIGH Capital Management LLC lifted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 479.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,150,000 shares of the biopharmaceutical company's...

Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss

Ardelyx (NASDAQ:ARDX) Shares Gap Down Following Weak Earnings...

Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, missing the consensus...

Ardelyx (ARDX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -15.39% and +3.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ardelyx Q1 Earnings Call Highlights

Ardelyx (NASDAQ:ARDX) executives said the company entered 2026 with "another significant year of growth" underway, highlighting strong first-quarter demand for its IBS-C product IBSRELA and continued momentum for kidney disease drug XPHOZAH, while also advancing pipeline efforts aimed at expanding t...

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.05
Prev Close	$5.84
Open	$5.90
Dividend Yield	0.00%
50-Day Moving Average	$6.15
Beta	1.01
Avg. Volume	4.09M
PE Ratio	-25.40

52-Week High	$8.40
52-Week Low	$3.49
Market Capitalization	$1.44B
EPS (Annual)	-$0.2556
Price to Book	10.05
Revenue Per Employee	$832,965.23

ARDXArdelyx Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARDX News